Scholar Rock Holding (SRRK) Non-Current Assets (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Non-Current Assets of $20.0 million in Q1 2026, up 4.42% quarter-over-quarter from $19.1 million in Q4 2025, and down 10.47% on a YoY basis from $22.3 million in Q1 2025.

Scholar Rock Holding (SRRK) Non-Current Assets (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non-Current Assets history runs 10 years deep, the most recent figure standing at $20.0 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 10.47% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $81.0 million (down 18.98% YoY), while the FY2025 annual figure was $19.1 million, down 19.5% from the prior year.
  • Non-Current Assets was $20.0 million for Q1 2026 at Scholar Rock Holding, up from $19.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $37.4 million in Q1 2022 to a low of $19.1 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $25.5 million across 5 years, with a median of $23.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Assets slumped 32.02% in 2023, then climbed 17.92% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $30.1 million in 2022, then declined by 24.23% to $22.8 million in 2023, then rose by 4.01% to $23.8 million in 2024, then slipped by 19.5% to $19.1 million in 2025, then gained by 4.42% to $20.0 million in 2026.
  • The last three Non-Current Assets figures came in at $20.0 million (Q1 2026), $19.1 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 19.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.97 Mn
Dec 31, 2025 19.13 Mn
Sep 30, 2025 21.01 Mn
Jun 30, 2025 20.92 Mn
Mar 31, 2025 22.31 Mn
Dec 31, 2024 23.76 Mn
Sep 30, 2024 26.21 Mn
Jun 30, 2024 27.73 Mn
Mar 31, 2024 20.35 Mn
Dec 31, 2023 22.84 Mn
Sep 30, 2023 22.22 Mn
Jun 30, 2023 25.09 Mn
Mar 31, 2023 27.56 Mn
Dec 31, 2022 30.14 Mn
Sep 30, 2022 32.69 Mn
Jun 30, 2022 34.99 Mn
Mar 31, 2022 37.39 Mn
Dec 31, 2021 39.13 Mn
Sep 30, 2021 40.23 Mn
Jun 30, 2021 41.69 Mn